Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
about
Profile of nintedanib in the treatment of solid tumors: the evidence to dateCheiradone: a vascular endothelial cell growth factor receptor antagonist.Evaluation of poly-mechanistic antiangiogenic combinations to enhance cytotoxic therapy response in pancreatic cancer.Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer.Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II.Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancerTGFβ signaling in pancreatic ductal adenocarcinoma.The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.
P2860
Q26775134-B576BC7D-BDC8-4CD1-BB57-375062679311Q33317046-D3F2AD5F-D249-48B0-9E49-239FE92B9C6DQ34313870-0337ACB2-C00A-454C-A865-D162BCC775FAQ35670576-09487730-2FE8-4A0C-91DB-E4A1D4E0A8E4Q36744817-6C09E002-8B68-4687-8677-274E3A9A160FQ36782405-FF7BFE25-22B6-44F2-B8F7-216BDA709C59Q38943965-7A9D84EA-882C-4737-B114-1388D1389AFDQ39635470-B03185FB-D008-4832-B143-787D4C8EEDD2
P2860
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
@ast
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
@en
type
label
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
@ast
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
@en
prefLabel
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
@ast
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
@en
P2860
P1476
Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.
@en
P2093
Elwyn Cabebe
George A Fisher
P2860
P304
P356
10.1517/13543784.16.4.467
P407
P577
2007-04-01T00:00:00Z